Literature DB >> 15636489

Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculous infection in India?

V K Chadha1, P S Jagannatha, P Kumar.   

Abstract

SETTING: Selected villages in three defined zones of India.
OBJECTIVES: To compare the estimated prevalence of tuberculous infection among children with and without bacille Calmette-Guérin (BCG) scar. STUDY
DESIGN: During a nationwide tuberculin survey, 1-9-year-old children were tuberculin tested using 1TU-PPD RT23 with Tween 80.
RESULTS: In the 5-9 year age group, subgroups of tuberculous infected children could be seen as distinct humps among those with or without BCG scar, but not in those aged 1-4 years. In children aged 1-4 years, the estimated prevalence of infection was respectively 3.5%, 3.8% and 3.6% among children without BCG scar, and 4.8%, 4.7% and 4.5% among children with BCG scar in the western, northern and eastern zones. In those aged 5-9 years, the estimated prevalence was respectively 10.4%, 11.0% and 9.1% among children without BCG scar and 11%, 11.9% and 8.7% among children with BCG scar in the three zones. Thus, in children aged 1-4 years, the estimated prevalence among those with BCG scar was considerably higher than in those without BCG scar. This difference was small in those aged 5-9 years.
CONCLUSION: Tuberculin surveys may be conducted irrespective of BCG scar status among children aged 5-9 years, when BCG vaccination is given using Danish 1331 strain during infancy under the Expanded Program of Immunization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15636489

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Strength of Tuberculin Used in the Mantoux Test: Does It Make a Difference?

Authors:  Joseph L Mathew
Journal:  Indian J Pediatr       Date:  2017-08-11       Impact factor: 1.967

2.  Protective effect of BCG among children vaccinated under universal immunization programme.

Authors:  V K Chadha; L Suryanarayana; H V Suryanarayan; N Srikantaramu; P Kumar
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

3.  Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children.

Authors:  K Okada; T E Mao; T Mori; T Miura; T Sugiyama; T Yoshiyama; S Mitarai; I Onozaki; N Harada; S Saint; K S Kong; Y M Chhour
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

4.  Comparison of quantiferon test with tuberculin skin test for the detection of tuberculosis infection in children.

Authors:  Hatice Onur; Sami Hatipoğlu; Vefik Arıca; Nevin Hatipoğlu; Seçil Gunher Arica
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

5.  Trend in annual risk of tuberculous infection in north India.

Authors:  Kamal Chopra; Vineet K Chadha; Jitendra Ramachandra; Nishi Aggarwal
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

6.  Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study.

Authors:  Hanan H Balkhy; Kamel El Beltagy; Aiman El-Saed; Badr Aljasir; Abdulhakeem Althaqafi; Adel F Alothman; Mohammad Alshalaan; Hamdan Al-Jahdali
Journal:  Ann Thorac Med       Date:  2016 Jul-Sep       Impact factor: 2.219

7.  Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).

Authors:  Margret Johansson Gudjónsdóttir; Karsten Kötz; Ruth Stangebye Nielsen; Philip Wilmar; Sofia Olausson; Daniel Wallmyr; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-10-06       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.